Patent application number | Description | Published |
20090004310 | SALACIA CUSPIDATA EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 01-01-2009 |
20090011060 | CAMPSIANDRA ANGUSTIFOLIA EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 01-08-2009 |
20090017140 | MAYTENUS ABENFOLIA EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 01-15-2009 |
20090022821 | COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES - The present invention relates to the use of certain novel compositions from wax myrtle ( | 01-22-2009 |
20090035395 | SPONDIAS MOMBIN L. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 02-05-2009 |
20090074891 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 03-19-2009 |
20090126048 | Method For Growing Forskohlin Containing Coleus In A Temperate Climate - The present invention is a method of growing and harvesting forskohlin-containing cultivars of the | 05-14-2009 |
20100047354 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 02-25-2010 |
20120237619 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 09-20-2012 |
20120321728 | NUTRITIONAL FORMULA FOR MANAGING ANGINA PECTORIS - The present invention is a novel nutritional product composition, formulated to be used as medical foods for managing blood flow related problems. The formula comprises clary sage root extract highly enriched for Tanshinones L-arginine, niacin, vitamin C, Vitamin B6, vitamin B12, folate and soy isoflavones. The composition enhances the increased blood flow to the muscle mass. Tanshinone IIA is an inducer of heme oxygenase 1 and suppressor of the induction of inducible nitric oxide synthase, which could result in desirable effects on two important gaseous signaling molecules, namely carbon monoxide and nitric oxide that have significant anti-inflammatory properties. | 12-20-2012 |
20120321729 | NUTRITIONAL FORMULA FOR MANAGING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND LUNG HEALTH - The present invention is a novel nutritional product composition formulated to be used as medical foods for managing COPD. The formula comprises clary sage root extract, L-Leucine, L-Isoleucine, L-Valine and L-Glutamine. The most active chemicals that import antioxidants proprieties are Tanshinones. The composition enhances the activity of Phase 2 enzymes that deactivate and react to oxygen species and many toxins present in tobacco smoke. Preparation of highly enriched Tanshinones improved the lung function in patients with chronic asthmatic bronchitis. | 12-20-2012 |
20140178506 | COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of | 06-26-2014 |